Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib.

ABSTRACT:

SUBMITTER: Zhou A 

PROVIDER: S-EPMC11223714 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature